• Invest
    Investment Suite
    Stocks
    Mutual Funds
    Future and Options
    IPO
    Exchange Traded Funds
    Commodity
    Stockcase (Stock Baskets)
    Currency
    Non Convertible Debentures
    Sovereign Gold Bond
    Exclusive
    NRI Account
    Private Client Group
    Features
    SipIt
    MTF
    Investment Suite
    Exclusive
    Features
  • Platform
    Product Suite
    Kotak Neo App & Web
    Nest Trading Terminal
    NEO Trade APIs
    Features and Tools
    MTF
    Securities Accepted as Collateral
    Margin Requirements
    Equity Screeners
    Payoff Analyzer
    Calculators
    SIP Calculator
    Lumpsum Calculator
    Brokerage Calculator
    Margin Calculator
    MTF Calculator
    SWP Calculator
    CAGR Calculator
    Simple Interest Calculator
    ELSS Calculator
    Step up SIP Calculator
    All Calculators
    Product Suite
    Features and Tools
    Calculators
  • Pricing
  • Research
    Research Calls
    Long Term calls
    Short Term calls
    Intraday calls
    Derivatives calls
    Pick of the week
    Top Monthly Picks
    Research Reports
    Fundamental Research Report
    Technical Research Report
    Derivative Research Report
    Research Calls
    Research Reports
  • Market
    Stocks
    Market Movers
    Large Cap
    Mid Cap
    Small Cap
    Indices
    Nifty 50
    Bank Nifty
    FinNifty
    Nifty Midcap India
    VIX
    All Indian Indices
    Mutual Funds
    SBI Mutual Funds
    HDFC Mutual Funds
    Axis Mutual Funds
    ICICI Prudential Mutual Funds
    Nippon India Mutual Funds
    All AMC's
    IPO
    Upcoming IPO
    Current IPO
    Closed IPO
    Recently Listed IPO
    Stocks
    Indices
    Mutual Funds
    IPO
  • Learn
    Resource
    Market Ready
    Kotak Insights
    Infographic
    Podcast
    Webinars
    Youtube Channel
    Quarterly Results
    Investing Guide
    Demat Account
    Trading Account
    Share Market
    Intraday Trading
    IPO
    Mutual Funds
    Commodities
    Currency
    Futures & Options
    Derivatives
    Margin Trading
    Events
    Budget 2024
    Muhurat Trading
    Share Market Holiday
    Market Outlook 2025
    Resource
    Investing Guide
    Events
  • Partner
    Business Associates
    Fund Expert
    Kotak Connect Plus
    Startup connect
  • Support
    FAQs
    Circulars
    Bulletins
    Contact Us
    Forms Download
    Get your Statement

Looking to Invest in Indegene Ltd’s IPO? Evaluate These Financial Metrics

  •  3 min read
  • 0
  • 03 May 2024
Looking to Invest in Indegene Ltd’s IPO? Evaluate These Financial Metrics

Key Highlights:

  • Indegene Ltd's total income has grown from Rs 1,664.61 crores in FY 22 to Rs 2,306.13 crores in FY 23 in FY 23

  • The company's PAT has risen to Rs 266.10 crores in FY 23 from Rs 164.76 crores in FY 22

  • Its ROE has grown to 25.02% in FY 23 from 21.57% in FY 22

  • The company's diluted EPS has grown to 11.97 in FY 23 from 7.46 in FY 22


Indegene Ltd, has launched an issue size of Rs 1841.76 crores within the price range of Rs 430-452, and generated considerable buzz among investors. Essential financial metrics are among the several aspects to evaluate before investing in a company's initial public offerng (IPO). If you plan to subscribe to an IPO, here are some financial metrices that deserve your attention.

  • Total income
    Total income refers to the company's aggregate money from all sources within a certain period. An increasing total income shows that a company generates more profit over time, which is a healthy sign. It shows a strong demand for the company's products and services with enhanced operational efficiency. Indegene Ltd's total income has steadily increased over the years. It grew from Rs 966.27 crores in FY 21 to Rs 1,664.61 crores in FY 22 and then rose to Rs 2,306.13 crores in FY 23.

  • Profit after tax
    Profit after tax or PAT is a company's net profit after deducting all expenses, including taxes, from its total revenues. A rising PAT suggests that a company's revenue is growing at a healthy rate. It also reflects a company's strong competitive positioning within the industry and shows that the company's management is efficiently allocating resources to boost profits. Like total income, Indegene Ltd's PAT has witnessed a considerable rise over the years. It grew to Rs 266.10 crores in FY 23 from Rs 164.76 crores in FY 22.

  • Return on Equity
    Return on Equity (ROE) shows how efficiently a company generates profits from its shareholders' equity. A high ROE shows that a company is prudent in using its shareholders' equity and is effectively using its resources to generate returns. A rising ROE also indicates that the company has the potential for future growth. This boosts investors' confidence and can enhance a company's stock value. Indegene Ltd has recorded a high ROE over the years. It stood at 25.02% in FY 23, rising from 21.57% in FY 22.

  • Diluted Earnings Per Share A diluted earnings per share (EPS) shows a detailed view of a company's profitability. Employing numerous criteria in the calculation, a rising diluted EPS shows that a firm's earnings are on the rise on a per-share basis. It is a positive sign for investors as it suggests that a company generates higher returns relative to the number of outstanding shares. Indegene Ltd's diluted EPS has been on a growth trajectory, rising to 11.97 in FY 23 from 7.46 in FY 22 and 8.74 in FY 21.

Summing it up

These key financial indicators show Indegene Ltd’s solid financial position. They show that the company is financially well poised for growth and to capture market opportunities. That said, you must thoroughly evaluate the risks and consider your goals before subscribing to its IPO.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their own research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.

Investments in securities market are subject to market risks, read all the related documents carefully before investing. Please read the SEBI prescribed Combined Risk Disclosure Document prior to investing. Brokerage will not exceed SEBI prescribed limit.

Source: RHP

FAQs

Indegene Ltd's profit after tax has grown to Rs 266.10 crores in FY 23 from Rs 164.76 crores in FY 22.

Indegene is a large company with 17 offices across the globe and 5000+ team members worldwide.

Did you enjoy this article?

0 people liked this article.

What could we have done to make this article better?

Enjoy Free Demat Account Opening
+91 -

personImage
Enjoy Free Demat Account Opening
+91 -

N
N
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]